In September, HHS took over distribution of the country’s monoclonal antibody supply, with weekly allotments based on local utilization rates, COVID-19 case burden and hospitalizations. States had previously ordered the drug directly from distributors.
Mr. DeSantis said Florida is waiting to receive enough doses to open five or 10 more antibody treatment sites.
“We do not believe that the federal government should be holding back any more medications,” Mr. DeSantis said during a Jan. 3 media briefing. “We have to offer this particularly for our elderly population.”
Last month, HHS temporarily paused distribution of Eli Lilly and Regeneron’s antibody drugs, which appear less effective against the omicron variant. The agency has since resumed these shipments.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
